297 related articles for article (PubMed ID: 21251242)
1. Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity.
Moseng L; Sæter M; Mørch-Johnsen GH; Hoff JM; Gajda A; Brodtkorb E; Midelfart A
Acta Ophthalmol; 2011 Aug; 89(5):452-8. PubMed ID: 21251242
[TBL] [Abstract][Full Text] [Related]
2. Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity.
Lawthom C; Smith PE; Wild JM
Ophthalmology; 2009 Mar; 116(3):565-71. PubMed ID: 19168223
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication.
Kjellström U; Andréasson S; Ponjavic V
Acta Ophthalmol; 2014 Mar; 92(2):149-57. PubMed ID: 23387307
[TBL] [Abstract][Full Text] [Related]
4. Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer.
Wild JM; Robson CR; Jones AL; Cunliffe IA; Smith PE
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):917-24. PubMed ID: 16505024
[TBL] [Abstract][Full Text] [Related]
5. Retinal nerve fiber layer thickness in vigabatrin-exposed patients.
Clayton LM; Dévilé M; Punte T; Kallis C; de Haan GJ; Sander JW; Acheson J; Sisodiya SM
Ann Neurol; 2011 May; 69(5):845-54. PubMed ID: 21246602
[TBL] [Abstract][Full Text] [Related]
6. Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals.
Clayton LM; Devile M; Punte T; de Haan GJ; Sander JW; Acheson JF; Sisodiya SM
Ophthalmology; 2012 Oct; 119(10):2152-60. PubMed ID: 22853973
[TBL] [Abstract][Full Text] [Related]
7. Retinal nerve fibre layer characteristics with vigabatrin-associated visual field loss--could scanning laser polarimetry aid diagnosis?
Durnian JM; Clearkin LG
Eye (Lond); 2008 Apr; 22(4):559-63. PubMed ID: 17401319
[TBL] [Abstract][Full Text] [Related]
8. Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy.
Conway M; Cubbidge RP; Hosking SL
Epilepsia; 2008 Jan; 49(1):108-16. PubMed ID: 18184224
[TBL] [Abstract][Full Text] [Related]
9. Binasal visual field defects are not specific to vigabatrin.
Gonzalez P; Sills GJ; Parks S; Kelly K; Stephen LJ; Keating D; Dutton GN; Brodie MJ
Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin-attributable visual field defects in patients with intractable partial epilepsy.
Tseng YL; Lan MY; Lai SL; Huang FC; Tsai JJ
Acta Neurol Taiwan; 2006 Dec; 15(4):244-50. PubMed ID: 17214087
[TBL] [Abstract][Full Text] [Related]
11. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?
Schmidt T; Rüther K; Jokiel B; Pfeiffer S; Tiel-Wilck K; Schmitz B
J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456
[TBL] [Abstract][Full Text] [Related]
12. Glaucoma detection by Stratus OCT.
Hougaard JL; Heijl A; Bengtsson B
J Glaucoma; 2007 May; 16(3):302-6. PubMed ID: 17438424
[TBL] [Abstract][Full Text] [Related]
13. Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin.
Werth R; Schädler G
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3028-35. PubMed ID: 16799049
[TBL] [Abstract][Full Text] [Related]
14. Reduction of retinal nerve fiber layer thickness in vigabatrin-exposed patients: A meta-analysis.
Peng Y; Zhao Y; Hu W; Hu Y; He Y; Zhou Y
Clin Neurol Neurosurg; 2017 Jun; 157():70-75. PubMed ID: 28412542
[TBL] [Abstract][Full Text] [Related]
15. Vigabatrin-associated visual field defects in children.
Russell-Eggitt IM; Mackey DA; Taylor DS; Timms C; Walker JW
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():334-9. PubMed ID: 11026995
[TBL] [Abstract][Full Text] [Related]
16. Retinal structure and function in vigabatrin-treated adult patients with refractory complex partial seizures.
Sergott RC; Johnson CA; Laxer KD; Wechsler RT; Cherny K; Whittle J; Feng G; Lee D; Isojarvi J
Epilepsia; 2016 Oct; 57(10):1634-1642. PubMed ID: 27580566
[TBL] [Abstract][Full Text] [Related]
17. Visual fields at school-age in children treated with vigabatrin in infancy.
Gaily E; Jonsson H; Lappi M
Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of retinal nerve fiber layer progression in glaucoma: a study on optical coherence tomography guided progression analysis.
Leung CK; Cheung CY; Weinreb RN; Qiu K; Liu S; Li H; Xu G; Fan N; Pang CP; Tse KK; Lam DS
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):217-22. PubMed ID: 19684001
[TBL] [Abstract][Full Text] [Related]
19. In utero exposure to vigabatrin: no indication of visual field loss.
Lawthom C; Smith PE; Wild JM
Epilepsia; 2009 Feb; 50(2):318-21. PubMed ID: 18616557
[TBL] [Abstract][Full Text] [Related]
20. The Topographical Relationship between Visual Field Loss and Peripapillary Retinal Nerve Fibre Layer Thinning Arising from Long-Term Exposure to Vigabatrin.
Wild JM; Aljarudi S; Smith PEM; Knupp C
CNS Drugs; 2019 Feb; 33(2):161-173. PubMed ID: 30637668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
